Drug Type Chemical drugs |
Synonyms RM-042 |
Target |
Mechanism RAS inhibitors(RAS type GTPase family inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Ductal Adenocarcinoma | Preclinical | US | 17 Apr 2023 |